How To Earn $500 A Month From PepsiCo Stock Ahead Of Q4 Earnings
Benzinga· 2026-02-02 13:00
PepsiCo, Inc. (NASDAQ:PEP) will release earnings for its fourth quarter before the opening bell on Tuesday, Feb. 3.Analysts expect the company to report quarterly earnings of $2.24 per share. That’s up from $1.96 per share in the year-ago period. The consensus estimate for PepsiCo's quarterly revenue is $28.97 billion (it reported $27.78 billion last year), according to Benzinga Pro.Ahead of quarterly earnings, UBS analyst Peter Grom, on Jan. 14, maintained PepsiCo with a Buy and lowered the price target fr ...
Sun Life Global Investments Expands ETF Series Lineup with New Low Volatility Offerings - Sun Life Financial (NYSE:SLF)
Benzinga· 2026-02-02 13:00
*Effective January 12, 2026, the Sun Life MFS Low Volatility Global Equity Fund was renamed SLGI MFS Blended Research Low Vol Global Fund, and the Sun Life MFS Low Volatility International Equity Fund was renamed SLGI MFS Blended Research Low Vol International Fund. Their investment objectives and strategies remain unchanged.The introduction of these new ETF series represents another enhancement to the two MFS Blended Research Low Vol funds, building on the recently announced management fee reductions. Bot ...
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
Globenewswire· 2026-02-02 13:00
For the treatment of aggression and social withdrawal MADRID and CAMBRIDGE, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that it has received a “Decision to grant” communication from the Japanese Patent Office for its patent application JP2023-136283, titled “Methods of treating behavior alterations”, related to vafidemstat, Oryzon’s LSD1 inhibitor in clinical deve ...
Apollo to Present at the UBS Financial Services Conference
Globenewswire· 2026-02-02 13:00
NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Martin Kelly, Chief Financial Officer, will participate in a fireside chat at the UBS Financial Services Conference on Tuesday, February 10, 2026 at 8:50 am ET. A live webcast of the event will be available on Apollo’s Investor Relations website at ir.apollo.com. For those unable to join live, a replay will be available shortly after the event. About Apollo Apollo is a high-growth, global alternative asset manager. In our as ...
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
Globenewswire· 2026-02-02 13:00
Industry’s Most Studied Placental Allografts Appear in Nearly 100 Clinical and Scientific PublicationsMARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the 15th anniversary of EPIFIX and AMNIOFIX, the Company’s placental allografts used in wound care and surgical recovery settings. “We are thrilled to mark the 15th anniversary of our flagship Wound and Surgical products, EPIFIX and AMNIOFIX, which have been instrumental to our pion ...
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
Globenewswire· 2026-02-02 13:00
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positive results from the Phase 2 LEDA trialThe upcoming Phase 3 program will therefore be expected to benefit from earlier and more frequent interactions with the FDA under the Fast Track program, potentially enabling a more efficient development pathway This regulatory decision follows the recent clear guidance from ...
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease
Globenewswire· 2026-02-02 13:00
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Instant NanoBiosensors Co., Ltd. (“INB”), a developer of cutting-edge biosensor platforms designed to improve biomedical rese ...
SunPower Secures $20 Million SEPA Agreement
Globenewswire· 2026-02-02 13:00
OREM, Utah, Feb. 02, 2026 (GLOBE NEWSWIRE) -- SunPower Inc. (herein “SunPower,” the “Company,” or Nasdaq: “SPWR”), a solar technology, services, and installation company – today announced that it has secured a Standby Equity Purchase Agreement (SEPA) with an affiliate of Yorkville Advisors Global (“Yorkville”) for a committed $20 million in funding from newly issued stock. The SEPA vehicle includes a pre-paid advance feature, which SunPower can draw on subject to various predetermined conditions. The discre ...
Doman Building Materials Group Ltd. Announces Retirement of James Code and Appointment of New Chief Financial Officer
Globenewswire· 2026-02-02 13:00
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Doman Building Materials Group Ltd. (“Doman” or the “Company”) (TSX: DBM) announces the upcoming retirement of Chief Financial Officer, James Code, effective April 7, 2026. Following a planned succession process, the Company is pleased to announce the appointment of Darren Gw ...
Americans can now 'bet' on home prices, letting them profit without owning property. Here's what you need to know
Yahoo Finance· 2026-02-02 13:00
Wagering on specific outcomes is already popular in sports, politics and pop culture. Now, it’s moving into real estate. Platforms offered by the likes of Polymarket and Kalshi now allow users to “bet” on where median home prices in the U.S., or in certain cities, will rise or fall without having to buy or sell a house (1). Must Read Supporters say these prediction market platforms offer exposure to the housing market without the hurdles of down payments, mortgage approval or long-term ownership. But t ...